🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

CHEPLAPHARM Arzneimittel GmbH — Licensed Medicines

74 medicines held by CHEPLAPHARM Arzneimittel GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 74 products held by CHEPLAPHARM Arzneimittel GmbH
MedicineActive substanceLicence holderStatus
Actos
EU/1/00/150/002
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Actos
EU/1/00/150/005
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Actos 15 mg tablets
EU/1/00/150/001
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Actos 15 mg tablets
EU/1/00/150/003
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Actos 30 mg tablets
EU/1/00/150/004
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Actos 30 mg tablets
EU/1/00/150/006
Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Anexate 500 micrograms/5ml, solution for injection or infusion
PA1868/002/001
Flumazenil Cheplapharm Arzneimittel GmbH Marketed
Atacand 16 mg tablets
PA2239/010/003
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Marketed
Atacand 4 mg tablets
PA2239/010/001
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Not marketed
Atacand 8 mg tablets
PA2239/010/002
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Marketed
Atacand Plus 16 mg/12.5 mg tablets
PA2239/011/002
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Marketed
Atacand Plus 8 mg/12.5 mg tablets
PA2239/011/001
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress 16 mg Tablets
PA2239/014/004
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress 32 mg Tablets
PA2239/014/005
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress 4 mg Tablets
PA2239/014/002
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress 8 mg Tablets
PA2239/014/003
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress Plus 16 mg/12.5 mg tablets
PA2239/015/002
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress Plus 32 mg/12.5 mg tablets
PA2239/015/003
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress Plus 32 mg/25 mg tablets
PA2239/015/004
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Blopress Plus 8 mg/12.5 mg tablets
PA2239/015/001
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Calcichew 500mg Chewable Tablets
PA2239/013/001
Calcium carbonate CHEPLAPHARM Arzneimittel GmbH Marketed
Calcichew-D3 Forte 500 mg/400 IU Chewable Tablets
PA2239/013/002
Cholecalciferol, Calcium carbonate CHEPLAPHARM Arzneimittel GmbH Marketed
Calcichew-D3 Forte Double Strength 1000 mg/800 IU Chewable Tablets
PA2239/013/003
Calcium carbonate, Cholecalciferol concentrate (powder form) CHEPLAPHARM Arzneimittel GmbH Marketed
Cholestagel 625 mg film-coated tablets
EU/1/03/268/1-3
CHEPLAPHARM Arzneimittel GmbH
Competact 15 mg/850 mg film-coated tablets
EU/1/06/354/005-010
Pioglitazone, Metformin Hydrochloride CHEPLAPHARM Arzneimittel GmbH
Cymevene 500 mg powder for concentrate for solution for infusion
PA2239/003/001
Ganciclovir CHEPLAPHARM Arzneimittel GmbH Marketed
Eucardic 12.5 mg Tablets
PA2239/001/002
Carvedilol CHEPLAPHARM Arzneimittel GmbH Marketed
Eucardic 25 mg Tablets
PA2239/001/003
Carvedilol CHEPLAPHARM Arzneimittel GmbH Marketed
Eucardic 6.25 mg Tablets
PA2239/001/001
Carvedilol CHEPLAPHARM Arzneimittel GmbH Marketed
Fungizone 50 mg Powder for sterile concentrate
PA2239/004/001
Amphotericin b CHEPLAPHARM Arzneimittel GmbH Marketed
Hydrea 500 mg Hard Capsules
PA2239/021/001
Hydroxycarbamide CHEPLAPHARM Arzneimittel GmbH Marketed
Hypnovel 10 mg/2 ml Solution for Injection
PA2239/007/001
Midazolam hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Hypnovel 10 mg/5 ml Solution for Injection
PA2239/007/002
Midazolam hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Konakion MM Ampoules 10 mg/ml Solution for Injection and Oral Solution
PA2239/002/001
Phytomenadione CHEPLAPHARM Arzneimittel GmbH Marketed
Konakion MM Paediatric Ampoules 2 mg/ 0.2 ml oral solution or solution for injection
PA2239/002/002
Phytomenadione CHEPLAPHARM Arzneimittel GmbH Marketed
Lexotan 1.5mg Tablets
PA2239/008/001
Bromazepam CHEPLAPHARM Arzneimittel GmbH Marketed
Lexotan 3mg Tablets
PA2239/008/002
Bromazepam CHEPLAPHARM Arzneimittel GmbH Marketed
Locoid Cream 0.1 % w/w
PA2239/019/001
Hydrocortisone butyrate CHEPLAPHARM Arzneimittel GmbH Marketed
Locoid Lipocream 0.1% w/w Cream
PA2239/019/002
Hydrocortisone butyrate CHEPLAPHARM Arzneimittel GmbH Marketed
Losec MUPS 10 mg gastro-resistant tablets
PA2239/009/001
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Losec MUPS 20 mg gastro-resistant tablets
PA2239/009/002
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Losec MUPS 40 mg gastro-resistant tablets
PA2239/009/003
Omeprazole magnesium CHEPLAPHARM Arzneimittel GmbH Marketed
Midon 2.5 mg tablets
PA2239/016/001
Midodrine hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Midon 5 mg tablets
PA2239/016/002
Midodrine hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion
EU/1/00/141/001
DOXORUBICIN HYDROCHLORIDE CHEPLAPHARM Arzneimittel GmbH
One-Alpha 0.25 micrograms soft capsules
PA2239/017/002
Alfacalcidol CHEPLAPHARM Arzneimittel GmbH Marketed
One-Alpha 1 microgram soft capsules
PA2239/017/001
Alfacalcidol CHEPLAPHARM Arzneimittel GmbH Marketed
One-Alpha 2 micrograms/ml oral drops
PA2239/017/003
Alfacalcidol CHEPLAPHARM Arzneimittel GmbH Marketed
Questran 4g/sachet, Powder for oral suspension
PA2239/005/001
Colestyramine CHEPLAPHARM Arzneimittel GmbH Marketed
Rivotril 0.5 mg Tablets
PA2239/020/001
Clonazepam CHEPLAPHARM Arzneimittel GmbH Marketed
1 2

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.